Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease

Movement Disorders

Volumn 28, Issue 14, 2013, Pages 1930-1934

  Pachana, Nancy A ^a   Egan, Sarah J ^b   Laidlaw, Ken ^c   Dissanayaka, Nadeeka ^d,e   Byrne, Gerard J ^a,e   Brockman, Simone ^f   Marsh, Rodney ^e   Starkstein, Sergio ^f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Anxiety; Cognitive behavioral therapy; Depression; Measurement; Parkinson's disease

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE;

ANTICIPATORY ANXIETY; ANXIETY DISORDER; BECK ANXIETY INVENTORY; COGNITIVE THERAPY; DECREASED APPETITE; DEPRESSION; DISEASE COURSE; DRUG DEPENDENCE; DRUG WITHDRAWAL; DYSKINESIA; FACIAL EXPRESSION; FATIGUE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; GERIATRIC ANXIETY INVENTORY; GERIATRIC DEPRESSION SCALE; HAMILTON ANXIETY SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMPULSE CONTROL DISORDER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PANIC; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDER; SOCIAL PHOBIA; SOCIAL STIGMA; TREATMENT RESPONSE; TREMOR; WELLBEING;

ANXIETY; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; MEASUREMENT; PARKINSON'S DISEASE;

AGED; AGED, 80 AND OVER; ANXIETY; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; PARKINSON DISEASE;

EID: 84889642377     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25689     Document Type: Review

References (48)

1. Dorsey E, Constantinescu R, Thompson J, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;68:384-386.
2. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006;248(1-2):151-157.
3. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
4. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 2004;52:784-788.
5. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21:916-923.
6. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 2010;25:2493-2500.
7. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008;23:183-189.
8. Dissanayaka NN, Sellbach A, Silburn PA, O'Sullivan JD, Marsh R, Mellick GD. Factors associated with depression in Parkinson's disease. J Affect Disord 2011;132(1-2):82-88.
9. Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry 1999;174:307-311.
10. Dissanayaka NN, Sellbach A, Matheson S, et al. Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010;25:838-845.
11. Prediger RD, Matheus FC, Schwarzbold ML, Lima MM, Vital MA. Anxiety in Parkinson's disease: a critical review of experimental and clinical studies. Neuropharmacology 2012;62:115-124.
12. Carmin CN, Wiegartz PS, Scher C. Anxiety disorders in the elderly. Curr Psychiatry Rep 2000;2:13-19.
13. Fuentes K, Cox BJ. Prevalence of anxiety disorders in elderly adults: a critical analysis. J Behav Ther Exp Psychiatry 1997;28:269-279.
14. O'Connor DW. Do older Australians truly have low rates of anxiety and depression? A critique of the 1997 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2006;40:623-631.
15. Richard IH, Justus AW, Kurlan R. Relationship between mood and motor fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:35-41.
16. Rabinstein AA, Shulman LM. Management of behavioral and psychiatric problems in Parkinson's disease. Parkinsonism Relat Disord 2000;7:41-50.
17. Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 2006;113:211-220.
18. Weisskopf MG, Chen HL, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003;18:646-651.
19. Ellgring H, Seiler S, Perleth B, Frings W, Gasser T, Oertel W. Psychosocial-aspects of Parkinsons disease. Neurology. 1993;43(12 Suppl 6):S41-S44.
20. Ambermoon P, Carter A, Hall W, Dissanayaka N, O'Sullivan J. Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction? Addiction 2012;107:241-247.
21. Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O'Sullivan JD. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 2011;106:283-293.
22. Dissanayaka NN, Sellbach A, Matheson S, et al. Validity of Hamilton depression inventory in Parkinson's disease. Mov Disord 2007;22:399-403.
23. Matheson SF, Byrne GJ, Dissanayaka NN, et al. Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease. Australas J Ageing 2012;31:13-16.
24. Weintraub D, Saboe K, Stern MB. Effect of age on geriatric depression scale performance in Parkinson's disease. Mov Disord 2007;22:1331-1335.
25. Byrne GJ, Pachana NA. Development and validation of a short form of the Geriatric Anxiety Inventory-the GAI-SF. Int Psychogeriatr 2011;23:125-131.
26. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007;22:1077-1092.
27. Dissanayaka NN, O'Sullivan JD, Silburn PA, Mellick GD. Assessment methods and factors associated with depression in Parkinson's disease. J Neurol Sci 2011;310:208-210.
28. Leentjens AFG, Dujardin K, Marsh L, et al. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008;23:2015-2025.
29. Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE. Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study. Parkinsonism Relat Disord 2012;18:1084-1088.
30. Martinez-Martin P, Rojo-Abuin JM, Dujardin K, et al. Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis. Eur J Neurol 2013;20:1198-1203.
31. Frisina PG, Borod JC, Foldi NS, Tenenbaum HR. Depression in Parkinson's disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat 2008;4:81-91.
32. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: Guilford Press; 1979.
33. Leentjens AFG. Depression in Parkinson disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol 2004;17:120-126.
34. Richard IH, McDermott MP, Kurlan R, et al. A randomized double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 2012;78:1229-1236.
35. Laidlaw K, Thompson LW, Gallagher-Thompson D, Dick-Siskin L. Cognitive behaviour therapy with older people. Hoboken, NJ: John Wiley & Sons, Ltd.; 2003.
36. Laidlaw K, McAlpine S. Cognitive behaviour therapy: how is it different with older people? J Ration Emot Cogn Behav Ther. 2008;26:250-262.
37. Freund AM, Baltes PB. Selection, optimization, and compensation as strategies of life management: correlations with subjective indicators of successful aging. Psychol Aging 1998;13:531-543.
38. Dreisig H, Beckmann J, Wermuth L, Skovlund S, Bech P. Psychologic effects of structured cognitive psychotherapy in young patients with Parkinson disease: a pilot study. Nord J Psychiatry 1999;53:217-221.
39. Mohlman J, Reel DH, Chazin D, et al. A novel approach to treating anxiety and enhancing executive skills in an older adult with Parkinson's disease. Clin Case Stud 2010;9:74-90.
40. Gupta R. Treatment of depression in an elderly Asian Indian male: a cognitive behavioural approach. Clin Gerontol 2000;22:87-89.
41. Veazey C, Cook KF, Stanley M, Lai EC, Kunik ME. Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease. J Clin Psychol Med Settings 2009;16:243-253.
42. Lawson RA, Millar D, Brown RG, Burn DJ. Guided self-help for the management of worry in Parkinson's disease: a pilot study. J Parkinsons Dis 2013;3:61-68.
43. Cole K, Vaughan FL. Brief cognitive behavioural therapy for depression associated with Parkinson's disease: a single case series. Behav Cogn Psychoth 2005;33:89-102.
44. Feeney F, Egan S, Gasson N. Treatment of depression and anxiety in Parkinson's disease: a pilot study using group cognitive behavioural therapy. Clin Psychol 2005;9:31-38.
45. Farabaugh A, Locascio JJ, Yap L, et al. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics 2010;51:124-129.
46. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
47. Dobkin RD, Allen LA, Menza M. Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study. Mov Disord 2007;22:946-952.
48. Dobkin RD, Menza M, Allen LA, et al. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry 2011;168:1066-1074.